COGT
Price
$10.90
Change
-$0.00 (-0.00%)
Updated
Sep 27 closing price
44 days until earnings call
TNFA
Price
$1.53
Change
-$0.14 (-8.38%)
Updated
Sep 27 closing price
Ad is loading...

COGT vs TNFA

Header iconCOGT vs TNFA Comparison
Open Charts COGT vs TNFABanner chart's image
Cogent Biosciences
Price$10.90
Change-$0.00 (-0.00%)
Volume$405.29K
CapitalizationN/A
TNF Pharmaceuticals
Price$1.53
Change-$0.14 (-8.38%)
Volume$16.65K
CapitalizationN/A
View a ticker or compare two or three
COGT vs TNFA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
COGT vs. TNFA commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and TNFA is a Sell.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (COGT: $10.95 vs. TNFA: $1.66)
Brand notoriety: COGT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 256% vs. TNFA: 32%
Market capitalization -- COGT: $1.19B vs. TNFA: $3.63M
COGT [@Biotechnology] is valued at $1.19B. TNFA’s [@Biotechnology] market capitalization is $3.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 0 green, 5 red.
According to our system of comparison, TNFA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 7 TA indicator(s) are bullish while TNFA’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 7 bullish, 2 bearish.
  • TNFA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, COGT is a better buy in the short-term than TNFA.

Price Growth

COGT (@Biotechnology) experienced а +9.94% price change this week, while TNFA (@Biotechnology) price change was -11.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

COGT is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.19B) has a higher market cap than TNFA($3.63M). TNFA YTD gains are higher at: 542.984 vs. COGT (86.224).
COGTTNFACOGT / TNFA
Capitalization1.19B3.63M32,892%
EBITDAN/AN/A-
Gain YTD86.224542.98416%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash36.9MN/A-
Total Debt18.5MN/A-
FUNDAMENTALS RATINGS
COGT vs TNFA: Fundamental Ratings
COGT
TNFA
OUTLOOK RATING
1..100
7987
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
8379
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4562
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (39) in the Medical Specialties industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that TNFA’s stock grew somewhat faster than COGT’s over the last 12 months.

TNFA's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as COGT (83) in the Miscellaneous industry. This means that TNFA’s stock grew similarly to COGT’s over the last 12 months.

TNFA's SMR Rating (97) in the Medical Specialties industry is in the same range as COGT (98) in the Miscellaneous industry. This means that TNFA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (45) in the Miscellaneous industry is in the same range as TNFA (62) in the Medical Specialties industry. This means that COGT’s stock grew similarly to TNFA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as TNFA (100) in the Medical Specialties industry. This means that COGT’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTTNFA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
86%
Bearish Trend about 2 months ago
90%
BollingerBands
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with KROS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+1.96%
KROS - COGT
45%
Loosely correlated
+5.38%
XFOR - COGT
40%
Loosely correlated
-5.80%
TNFA - COGT
39%
Loosely correlated
-1.57%
CRSP - COGT
36%
Loosely correlated
-4.61%
NTLA - COGT
35%
Loosely correlated
-3.65%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with AZTR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
-1.57%
AZTR - TNFA
50%
Loosely correlated
-7.75%
COGT - TNFA
39%
Loosely correlated
+1.96%
COEP - TNFA
37%
Loosely correlated
-2.69%
TVGN - TNFA
37%
Loosely correlated
-9.75%
LRMR - TNFA
32%
Poorly correlated
-12.52%
More